Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth

Oncotarget

Volumn 6, Issue 24, 2015, Pages 20540-20554

  Shi, Ying ^a   Chen, Guo Bin ^a   Huang, Xiao Xiao ^a   Xiao, Chuan Xing ^a   Wang, Huan Huan ^a   Li, Ye Sen ^a,d   Zhang, Jin Fang ^b   Li, Shao ^e   Xia, Yin ^b,c   Ren, Jian Lin ^a   Guleng, Bayasi ^a  

^a XIAMEN UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^e TSINGHUA UNIVERSITY   (China)

Author keywords

BMP; Colorectal cancer; Dragon; Erk1 2; Proliferation; Smad1 5 8

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN DRAGON; PROTEIN RGMB; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; RGMB PROTEIN, HUMAN; RGMB PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER MODEL; CANCER TISSUE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRAGON GENE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR GENE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; COLORECTAL TUMOR; DRUG SCREENING; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84940185193     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4110     Document Type: Article

References (41)

1. Edwards BK, Noone A-M, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR and Ward EM. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120:1290-1314.
2. Mark Feldman MD, Bruce F. Scharschmidt MD and Marvin H. Sleisenger MD. (2001). Sleisenger & Fordtran's Gastrointestinal and Liver Disease. (China: Harcourt Asia, W. B. Saunders).
3. Jemal A, Siegel R, Xu J and Ward E. Cancer Statistics, 2010. CACANCER J CLIN. 2010; 60:277-300.
4. Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N and Papavassiliou AG. TGF-beta signalling in colon carcinogenesis. Cancer letters. 2012; 314:1-7.
5. Derynck R and Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. NATURE. 2003; 425:577-584.
6. Monnier PP, Sierra A, Macchi P, Deitinghoff L, Andersen JS, Mann M, Fladk M, Hornberger MR, Stahl B, Bonhoeffer F and Mueller BK. RGM is a repulsive guidance molecule for retinal axons. NATURE. 2002; 419:392-395.
7. Halbrooks PJ, Ding R, Wozney JM and Bain G. Role of RGM coreceptors in bone morphogenetic protein signaling. Journal of molecular signaling. 2007; 2:4.
8. Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L and Woolf CJ. DRAGON, a bone morphogenetic protein co-receptor. The Journal of biological chemistry. 2005; 280:14122-14129.
9. Samad TA, Srinivasan A, Karchewski LA, Jeong SJ, Campagna JA, Ji RR, Fabrizio DA, Zhang Y, Lin HY, Bell E and Woolf CJ. DRAGON: a member of the repulsive guidance molecule-related family of neuronal-and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2004; 24:2027-2036.
10. Xia Y, Babitt JL, Bouley R, Zhang Y, Da Silva N, Chen S, Zhuang Z, Samad TA, Brenner GJ, Anderson JL, Hong CC, Schneyer AL, Brown D and Lin HY. Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. Journal of the American Society of Nephrology: JASN. 2010; 21:666-677.
11. Liu W, Li X, Zhao Y, Meng XM, Wan C, Yang B, Lan HY, Lin HY and Xia Y. Dragon (repulsive guidance molecule RGMb) inhibits E-cadherin expression and induces apoptosis in renal tubular epithelial cells. The Journal of biological chemistry. 2013; 288:31528-31539.
12. Xia Y, Cortez-Retamozo V, Niederkoflfler V, Salie R, Chen S, Samad TA, Hong CC, Arber S, Vyas JM, Weissleder R, Pittet MJ and Lin HY. Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. Journal of immunology. 2011; 186:1369-1376.
13. Conrad S, Stimpflfle F, Montazeri S, Oldekamp J, Seid K, Alvarez-Bolado G and Skutella T. RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo. Molecular and cellular neurosciences. 2010; 43:222-231.
14. Matsunaga E, Tauszig-Delamasure S, Monnier PP, Mueller BK, Strittmatter SM, Mehlen P and Chedotal A. RGM and its receptor neogenin regulate neuronal survival. Nature cell biology. 2004; 6:749-755.
15. Rajagopalan S, Deitinghoff L, Davis D, Conrad S, Skutella T, Chedotal A, Mueller BK and Strittmatter SM. Neogenin mediates the action of repulsive guidance molecule. Nature cell biology. 2004; 6:756-762.
16. Samad TA. DRAGON, a Bone Morphogenetic Protein Co-receptor. Journal of Biological Chemistry. 2005; 280:14122-14129.
17. Xia Y, Babitt JL, Sidis Y, Chung RT and Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood. 2008; 111:5195-5204.
18. Andriopoulos B, Jr., Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY and Babitt JL. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41:482-487.
19. Xia Y, Babitt JL, Bouley R, Zhang Y, Da Silva N, Chen S, Zhuang Z, Samad TA, Brenner GJ, Anderson JL, Hong CC, Schneyer AL, Brown D and Lin HY. Dragon Enhances BMP Signaling and Increases Transepithelial Resistance in Kidney Epithelial Cells. Journal of the American Society of Nephrology. 2010; 21:666-677.
20. Schmidtmer J and Engelkamp D. Isolation and expression pattern of three mouse homologues of chick Rgm. Gene Expression Patterns. 2004; 4:105-110.
21. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC and Lin HY. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature genetics. 2006; 38:531-539.
22. Camus LM and Lambert LA. Molecular evolution of hemojuvelin and the repulsive guidance molecule family. Journal of molecular evolution. 2007; 65:68-81.
23. Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science. 2012; 335:348-353.
24. Wu X, Jiang R, Zhang MQ and Li S. Network-based global inference of human disease genes. Molecular systems biology. 2008; 4:189.
25. Xia Y, Sidis Y, Mukherjee A, Samad TA, Brenner G, Woolf CJ, Lin HY and Schneyer A. Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology. 2005; 146:3614-3621.
26. Hinck L and Nathke I. Changes in cell and tissue organization in cancer of the breast and colon. Current opinion in cell biology. 2014; 26C:87-95.
27. Deschaseaux F, Sensebe L and Heymann D. Mechanisms of bone repair and regeneration. Trends in molecular medicine. 2009; 15:417-429.
28. Bertrand FE, Angus CW, Partis WJ and Sigounas G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell cycle. 2012; 11:4344-4351.
29. Voorneveld PW, Kodach LL, Jacobs RJ, Liv N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes DW, de Rooij K, van Noesel CJ, Morreau H, van Wezel T, Offerhaus GJ, van den Brink GR, Peppelenbosch MP, Ten Dijke P, Hardwick JC. Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK. Gastroenterology. 2014; Epub 2014 Apr 3.
30. Lee JH, Lee GT, Woo SH, Ha YS, Kwon SJ, Kim WJ and Kim IY. BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer research. 2013; 73(12):3604-3614.
31. Dante R, He Y, Cui Y, Xu B, Gu J, Wang W and Luo X. Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma. PLoS ONE. 2014; 9:e87994.
32. Zheng Y, Wang X, Wang H, Yan W, Zhang Q and Chang X. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014.
33. Lee GT, Kang DI, Ha YS, Jung YS, Chung J, Min K, Kim TH, Moon KH, Chung JM, Lee DH, Kim WJ and Kim IY. Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. British journal of cancer. 2014; 110:1634-1644.
34. Ren W, Sun X, Wang K, Feng H, Liu Y, Fei C, Wan S, Wang W, Luo J, Shi Q, Tang M, Zuo G, Weng Y, He T and Zhang Y. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Molecular biology reports. 2014; 41:1373-1383.
35. Slattery ML, Lundgreen A, Herrick JS, Kadlubar S, Caan BJ, Potter JD and Wolff RK. Genetic variation in bone morphogenetic protein and colon and rectal cancer. International journal of cancer Journal international du cancer. 2012; 130:653-664.
36. Corradini E, Babitt JL and Lin HY. The RGM/DRAGON family of BMP co-receptors. Cytokine & growth factor reviews. 2009; 20:389-398.
37. Lorente-Trigos A, Varnat F, Melotti A and Ruiz i Altaba A. BMP signaling promotes the growth of primary human colon carcinomas in vivo. Journal of molecular cell biology. 2010; 2:318-332.
38. Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N, Zhang Z, Liao Z, Zeng L, Deng Y, Deng F, Zhang J, Yin L, Liu W, Zhang Q, Ya Z, Ye J, et al. Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncology reports. 2014; 32:1013-1020.
39. Shi Y and Massagué J. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus. Cell. 2003; 113:685-700.
40. Javelaud D and Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene. 2005; 24:5742-5750.
41. Xia Y, Yu PB, Sidis Y, Beppu H, Bloch KD, Schneyer AL and Lin HY. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. The Journal of biological chemistry. 2007; 282:18129-18140.